Eversept Partners
Latest statistics and disclosures from Eversept Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are QQQ, GSK, NTRA, SPY, TEVA, and represent 46.14% of Eversept Partners's stock portfolio.
- Added to shares of these 10 stocks: HQY (+$25M), INSP (+$22M), QQQ (+$18M), GSK (+$14M), SWAV (+$13M), IBB (+$8.6M), ELV (+$8.4M), TLT (+$8.3M), HCA (+$7.2M), VRDN (+$6.8M).
- Started 11 new stock positions in BBIO, TLT, TSHA, MRVI, IBB, AVTR, TSVT, HYG, VRDN, PODD. HQY.
- Reduced shares in these 10 stocks: Horizon Therapeutics (-$31M), CTLT (-$16M), ICLR (-$13M), Abcam Plc Ads (-$12M), AMRX (-$11M), RGEN (-$7.9M), MODN (-$7.9M), TEVA (-$7.3M), XENE (-$6.6M), CLDX (-$5.4M).
- Sold out of its positions in Abcam Plc Ads, CTLT, EHTH, EOLS, FGEN, GOCO, KURA, MODN, Paratek Pharmaceuticals, SPRY. XENE, ZLAB, URGN.
- Eversept Partners was a net buyer of stock by $58M.
- Eversept Partners has $1.2B in assets under management (AUM), dropping by -1.20%.
- Central Index Key (CIK): 0001697013
Tip: Access up to 7 years of quarterly data
Positions held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Eversept Partners
Eversept Partners holds 68 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 12.1 | $143M | +14% | 400k | 358.27 |
|
| GSK Sponsored Adr (GSK) | 10.0 | $118M | +13% | 3.3M | 36.25 |
|
| Natera (NTRA) | 9.3 | $110M | +3% | 2.5M | 44.25 |
|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 8.7 | $103M | +4% | 240k | 427.48 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 6.0 | $71M | -9% | 7.0M | 10.20 |
|
| United Therapeutics Corporation (UTHR) | 5.1 | $61M | +2% | 268k | 225.87 |
|
| Inspire Med Sys (INSP) | 3.2 | $38M | +134% | 193k | 198.44 |
|
| Syndax Pharmaceuticals (SNDX) | 3.2 | $38M | +18% | 2.6M | 14.52 |
|
| Hca Holdings (HCA) | 2.3 | $27M | +36% | 110k | 245.98 |
|
| Bio-techne Corporation (TECH) | 2.2 | $26M | +12% | 386k | 68.07 |
|
| Danaher Corporation (DHR) | 2.2 | $26M | 104k | 248.10 |
|
|
| Healthequity (HQY) | 2.1 | $25M | NEW | 339k | 73.05 |
|
| Horizon Therapeutics Pub L SHS | 2.0 | $24M | -56% | 206k | 115.69 |
|
| Illumina (ILMN) | 1.9 | $23M | +34% | 167k | 137.28 |
|
| Community Health Systems (CYH) | 1.8 | $21M | 7.1M | 2.90 |
|
|
| Vera Therapeutics Cl A (VERA) | 1.7 | $20M | -15% | 1.5M | 13.71 |
|
| BioCryst Pharmaceuticals (BCRX) | 1.5 | $18M | +4% | 2.5M | 7.08 |
|
| Shockwave Med (SWAV) | 1.4 | $17M | +319% | 85k | 199.10 |
|
| Celldex Therapeutics Com New (CLDX) | 1.4 | $16M | -25% | 588k | 27.52 |
|
| Centene Corporation (CNC) | 1.1 | $13M | +24% | 191k | 68.88 |
|
| Krystal Biotech (KRYS) | 1.1 | $13M | +2% | 109k | 116.00 |
|
| Ionis Pharmaceuticals (IONS) | 1.0 | $12M | +4% | 252k | 45.36 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.9 | $11M | -49% | 2.6M | 4.22 |
|
| Vaxcyte (PCVX) | 0.8 | $9.7M | -2% | 190k | 50.98 |
|
| Taro Pharmaceutical Inds SHS (TARO) | 0.8 | $9.6M | +2% | 255k | 37.71 |
|
| Anthem (ELV) | 0.8 | $9.4M | +837% | 22k | 435.42 |
|
| Liquidia Corporation Com New (LQDA) | 0.7 | $8.8M | +50% | 1.4M | 6.34 |
|
| Humana (HUM) | 0.7 | $8.8M | +51% | 18k | 486.52 |
|
| Ishares Tr Ishares Biotech Put Option (IBB) | 0.7 | $8.6M | NEW | 70k | 122.29 |
|
| Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT) | 0.7 | $8.3M | NEW | 94k | 88.69 |
|
| Amarin Corp Spons Adr New (AMRN) | 0.7 | $7.8M | -19% | 8.4M | 0.92 |
|
| Spdr Ser Tr S&p Biotech (XBI) | 0.6 | $7.3M | +11% | 100k | 73.02 |
|
| Miragen Therapeutics (VRDN) | 0.6 | $6.8M | NEW | 443k | 15.34 |
|
| Ishares Tr Iboxx Hi Yd Etf Put Option (HYG) | 0.6 | $6.6M | NEW | 90k | 73.72 |
|
| Waters Corporation (WAT) | 0.5 | $6.3M | +111% | 23k | 274.21 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.5 | $6.1M | -4% | 661k | 9.25 |
|
| 2seventy Bio Common Stock (TSVT) | 0.5 | $5.7M | NEW | 1.5M | 3.92 |
|
| Seres Therapeutics (MCRB) | 0.5 | $5.6M | -23% | 2.4M | 2.38 |
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.5 | $5.4M | NEW | 1.7M | 3.16 |
|
| Inflarx Nv (IFRX) | 0.4 | $5.2M | -9% | 1.7M | 2.98 |
|
| Icon SHS (ICLR) | 0.4 | $5.2M | -70% | 21k | 246.25 |
|
| Protagonist Therapeutics (PTGX) | 0.4 | $4.8M | +150% | 287k | 16.68 |
|
| Agilent Technologies Inc C ommon (A) | 0.4 | $4.7M | +46% | 42k | 111.82 |
|
| Apellis Pharmaceuticals (APLS) | 0.4 | $4.7M | +117% | 123k | 38.04 |
|
| Iqvia Holdings (IQV) | 0.4 | $4.5M | +22% | 23k | 196.75 |
|
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.4 | $4.5M | NEW | 452k | 10.00 |
|
| Puma Biotechnology (PBYI) | 0.4 | $4.4M | 1.7M | 2.63 |
|
|
| AMN Healthcare Services Put Option (AMN) | 0.4 | $4.3M | -47% | 50k | 85.18 |
|
| Pennant Group (PNTG) | 0.3 | $4.1M | -15% | 366k | 11.13 |
|
| Molina Healthcare (MOH) | 0.3 | $4.0M | -42% | 12k | 327.89 |
|
| Gossamer Bio (GOSS) | 0.3 | $3.7M | +490% | 4.4M | 0.83 |
|
| PerkinElmer (RVTY) | 0.3 | $3.6M | +53% | 33k | 110.70 |
|
| Curevac N V (CVAC) | 0.3 | $3.5M | +44% | 517k | 6.83 |
|
| Biohaven (BHVN) | 0.3 | $3.4M | 131k | 26.01 |
|
|
| Insulet Corporation (PODD) | 0.3 | $3.4M | NEW | 21k | 159.49 |
|
| Merus N V (MRUS) | 0.3 | $3.2M | +2% | 134k | 23.58 |
|
| Sutro Biopharma (STRO) | 0.2 | $2.7M | +2% | 770k | 3.47 |
|
| Repligen Corporation (RGEN) | 0.2 | $2.6M | -75% | 16k | 159.01 |
|
| Argenx Se Sponsored Adr (ARGX) | 0.2 | $2.2M | +9% | 4.6k | 491.63 |
|
| Medpace Hldgs (MEDP) | 0.2 | $2.1M | -43% | 8.8k | 242.13 |
|
| Avantor (AVTR) | 0.2 | $1.8M | NEW | 85k | 21.08 |
|
| Bridgebio Pharma Put Option (BBIO) | 0.1 | $1.5M | NEW | 56k | 26.37 |
|
| Xoma Corp Del Com New (XOMA) | 0.1 | $1.3M | 90k | 14.09 |
|
|
| Black Diamond Therapeutics (BDTX) | 0.1 | $968k | -21% | 337k | 2.87 |
|
| Affimed Therapeutics B V | 0.1 | $801k | 1.7M | 0.48 |
|
|
| Aerovate Therapeutics (AVTE) | 0.1 | $682k | 50k | 13.57 |
|
|
| Aadi Bioscience (AADI) | 0.0 | $493k | 102k | 4.84 |
|
|
| Ac Immune Sa SHS (ACIU) | 0.0 | $355k | 125k | 2.85 |
|
Past Filings by Eversept Partners
SEC 13F filings are viewable for Eversept Partners going back to 2017
- Eversept Partners 2023 Q3 filed Nov. 14, 2023
- Eversept Partners 2017 Q4 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q1 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q2 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q3 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q4 restated filed Nov. 8, 2023
- Eversept Partners 2019 Q1 restated filed Nov. 8, 2023
- Eversept Partners 2019 Q2 restated filed Nov. 8, 2023
- Eversept Partners 2019 Q3 restated filed Nov. 8, 2023
- Eversept Partners 2019 Q4 restated filed Nov. 8, 2023
- Eversept Partners 2020 Q1 restated filed Nov. 8, 2023
- Eversept Partners 2020 Q2 restated filed Nov. 8, 2023
- Eversept Partners 2020 Q3 restated filed Nov. 8, 2023
- Eversept Partners 2020 Q3 amended filed Nov. 8, 2023
- Eversept Partners 2020 Q4 restated filed Nov. 8, 2023
- Eversept Partners 2020 Q4 amended filed Nov. 8, 2023